Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 233 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cancer Lung Screening Clear all

Conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Sarcoma, Melanoma
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 1 Month and older
Enrollment: 19,522 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Melanoma, Gastrointestinal Cancer, Metastatic Cancer, Breast Cancer, Non-Small Cell Lung Cancer
Interventions: Anti-CD19 CAR PBL; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 7,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Early Detection of Cancer, Telemedicine, Decision Making
Interventions: Active Choice, Telehealth Only, Low Touch Strategy, High Touch Strategy; Behavioral
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 50 Years to 80 Years
Enrollment: 6,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Melanoma, Li-Fraumeni Syndrome, Pulmonary Blastoma, Chordoma, Congenital Bone Marrow Failure Syndromes, Costello Syndrome, Fanconi Anemia, CFC Syndrome (CFCS), Legius Syndrome, RASopathies
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 1 Year to 99 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Lung Cancer
Interventions: Blood collection; Other
Lead sponsor: Nucleix Ltd.; Industry
Eligibility: 20 Years to 80 Years
Enrollment: 2,132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 6
States / cities: Miami, Florida • Panama City, Florida • Shreveport, Louisiana + 3 more

Conditions: Lung Cancer
Interventions: Surveys, Focus groups, Cognitive Interviews, Lung cancer screening decision aid video, Colon cancer screening video; Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 50 Years to 80 Years
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Lung Cancer, Tobacco Use
Interventions: Community health worker delivered outreach, shared decision-making, tobacco treatment, and navigation, Lay Navigator delivered outreach, shared decision-making, tobacco treatment, and navigation, Enhanced Usual Care; Behavioral · Other
Lead sponsor: Baystate Medical Center; Other
Eligibility: 50 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: Lung Cancer
Interventions: chest computed tomography scan; Procedure
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2019
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Lung Cancer, Smoking Cessation, Tobacco Use Cessation
Interventions: Patient Decision Aid, Standard Educational Information, Follow-Up Assessments: Questionnaires; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 55 Years to 77 Years
Enrollment: 516 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Ridgeland, Mississippi

Conditions: Colon Cancer
Interventions: Shared Decision Making; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years to 75 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lung Cancer
Interventions: Tele-Navi LCS; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 50 Years to 77 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Smoking Cessation
Interventions: Computer-Assisted Intervention Video Doctor, Computer-Assisted Intervention no Video Doctor; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 55 Years to 80 Years
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Lung Cancer
Interventions: Small RNA-based lung cancer assay; Diagnostic Test
Lead sponsor: Hummingbird Diagnostics; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 11
States / cities: Atlanta, Georgia • Baton Rouge, Louisiana • Boston, Massachusetts + 7 more

Conditions: Lung Cancer
Interventions: LungCARE; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 55 Years to 80 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Triple Negative Breast Cancer, Non-small Cell Lung Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4, Advanced Breast Cancer, Advanced Lung Carcinoma, NSCLC, NSCLC, Recurrent, NSCLC Stage IV, Relapsed Cancer, Relapse/Recurrence, Recurrent Breast Cancer, Recurrent NSCLC, Platinum-resistant Ovarian Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Endometrioid Tumor, High Grade Serous Carcinoma, Ovarian Epithelial Cancer
Interventions: Not listed
Lead sponsor: Lyell Immunopharma, Inc.; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Rocky Mount, North Carolina

Conditions: Tobacco Use Disorder, Lung Cancer
Interventions: Non-intervention; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 55 Years to 74 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Coronary Artery Disease, Cardiovascular Diseases, Smoking
Interventions: Educational Letter Post CT Examination; Other
Lead sponsor: American College of Radiology; Other
Eligibility: 50 Years to 80 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Seattle, Washington

Conditions: Lung Neoplasms
Interventions: TELESCOPE, Remote Decision Coaching with Navigation Intervention; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 537 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: New Brunswick, New Jersey • Houston, Texas

Conditions: Lung Cancer, Health Screening, Early Cancer Detection, Deep Learning
Interventions: CXR-LC; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years to 77 Years
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Electronic Cigarette Use, Smoking, Cigarette, Nicotine Dependence
Interventions: NJOY ACE e-cigarette; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Previously Treated Non-Small Cell Lung Cancer
Interventions: Screening Platform; Drug
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 1229
States / cities: Birmingham, Alabama • Daphne, Alabama • Fairhope, Alabama + 807 more

Conditions: Lung Cancer
Interventions: Patient Navigation; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 675 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Carrboro, North Carolina • Charleston, South Carolina • Richmond, Virginia

Conditions: Non-small Cell Lung Cancer
Interventions: Not listed
Lead sponsor: St Elizabeth Healthcare; Other
Eligibility: 18 Years and older
Enrollment: 7,659 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Edgewood, Kentucky

Conditions: Colorectal Cancer, Lung Cancer, Breast Cancer
Interventions: Decision Making Support Tool; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 50 Years to 80 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Charleston, South Carolina

Search by objective public record fields.

Eligibility Screening for the NIH Intramural Research Program Clinical Protocols

Harvesting Cells for Experimental Cancer Treatments

Integrating Telehealth to Advance Lung Cancer Screening

Clinical Genetics Branch Eligibility Screening Survey

Lung EpiCheck Biomarkers Development Study

Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System

A Community Health Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease

PCORI-CER-1306-03385 Informed Decisions About Lung Cancer Screening

Engaging Patients in Colon Cancer Screening Decisions During COVID-19

Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)

CONNECT: Smoking Cessation and Lung Cancer Screening

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

Lung Cancer Screening: A Multilevel Intervention

A Biomarker Screening Protocol for Participants With Solid Tumors

Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1

Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health

TELESCOPE- TELEhealth Shared Decision-making COaching

Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT

Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Health Education Approach to Lung Screening

A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence

Technology-Based Cancer Screening Intervention